Browsing ‘Special Report’ Archives

Department of Health and Human Services Releases Intended Targets for Medicare Price Negotiations

Surprises and Unanswered Questions in the List of Drugs Selected for Direct Negotiations What happened? The Department of Health and Human Services (HHS) released its intended targets for Medicare price negotiations on August 29, 2023, putting affected biopharmaceutical companies on official notice for lower Medicare reimbursements in 2026 (and possible market repercussions more immediately). Need […]